| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.85▲ | 2.85▲ | 2.85▲ | 2.84▼ | 3.18▼ |
| MA10 | 2.83▲ | 2.83▲ | 2.83▲ | 2.90▼ | 3.50▼ |
| MA20 | 2.80▲ | 2.81▲ | 2.83▲ | 3.17▼ | 4.23▼ |
| MA50 | 3.16▼ | 3.18▼ | 3.23▼ | 3.63▼ | 2.48▲ |
| MA100 | 3.46▼ | 3.51▼ | 3.50▼ | 4.40▼ | N/A |
| MA200 | 3.60▼ | 4.44▼ | 5.06▼ | 2.72▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.032▲ | 0.032▲ | 0.031▲ | 0.011▲ | -0.319▼ |
| RSI | 45.269▼ | 44.607▼ | 43.359▼ | 30.786▼ | 44.192▼ |
| STOCH | 68.676 | 67.059 | 67.059 | 25.535 | 6.216▼ |
| WILL %R | -30.000 | -30.000 | -30.000 | -78.571▼ | -96.803▼ |
| CCI | 68.421 | 68.536 | 68.369 | -61.045 | -78.700 |
| ▼ GAP | $SLXN Open Gap Down %2 | Set Alert |
|
Wednesday, November 12, 2025 06:07 AM
Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 2.80 | 2.928 | 2.74 | 2.84 | 40,767 |
| 13/11/25 | 2.9059 | 3.03 | 2.83 | 2.87 | 18,518 |
| 12/11/25 | 2.79 | 2.91 | 2.765 | 2.91 | 24,536 |
| 11/11/25 | 2.79 | 2.815 | 2.69 | 2.81 | 19,067 |
| 10/11/25 | 2.74 | 2.96 | 2.71 | 2.78 | 53,197 |
| 07/11/25 | 2.76 | 2.833 | 2.66 | 2.79 | 50,358 |
| 06/11/25 | 2.97 | 2.99 | 2.68 | 2.87 | 114,900 |
| 05/11/25 | 3.05 | 3.05 | 2.96 | 2.99 | 49,574 |
| 04/11/25 | 3.08 | 3.14 | 2.85 | 3.00 | 55,487 |
| 03/11/25 | 3.35 | 3.35 | 3.10 | 3.17 | 65,400 |
|
|
||||
|
|
||||
|
|